FDA Investigator Sherri N Rohlf, MD

Sherri N Rohlf, MD has inspections in 10 countries as of 15 Dec 2023. Sherri N Rohlf, MD has collaborated with a combinined 3538 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

157

Last Inspection Date:

15 Dec 2023

Investigator Role:

FDA Investigator

Redica ID:

100008261

Country:

United States of America, Poland, Belgium, Germany, Japan, France, India, Canada, Bulgaria

Co-Investigator(s):

Aaron J Poloni, Adam S Freeman, Alan P Kurtzberg, Alexander M Kay, Allan P Kurtzberg, Allen F Hall, Amanda E Lewin, PhD, Amber M Howell, Andersoneric, Angela Shepas, Anh Trinh T Nguyen, Anita Narula, PhD, Anthony E Keller, RPh, Armando Chavez, MS, Ashleigh P Barkans, Astrida B Mattson, Barbara J Rincon, Barbara Janine Breithaupt, Beau R Lamb, Betsy C Galliher, Bonita S Chester, Brenda L Reihing, Brenda L Reiling, Britton C Walker, Bryan Baker, Calvin K Cook, Carl A Anderson, Carla J Lundi, Carla V Jordan, CDR Thomas R Berry, PPh, Celia L Silverstein, Charles L Larson, Cheryl D Mccall, Christina D Mello, Christina L Norton, Christine I Shaw, Christine M Parmentier, Christopher S Genther, Connie P Rezendes, Courtney R Bratina, Craig T Rybus, Crystal A Harlan, Cynthia L Gorveatt, Dan G Eisenbrey, David R Heiar, Dawn E Barkans, Deborah A Nebenzahl, Deborah A Nebnzahl, Dennis G Kawabata, Devon M Shoop, Diane C Thibodeau, Diane Cvan Leeuwen, Dien N Nguyen, Dirk L Lincoln, Donald B Mckechnie, Douglas A Campbell, Durell L Giles, Dustin R Abaonza, Elizabeth S Howell, Eric L Scott, Eric M Mueller, PharmD, Felix Maldonado, Francis J Eng, Gajendiran Mahadevan, PhD, Gary L Zaharek, Gloria J Baca, MS, Graham N Giesen, Greg K Keshishyan, Harmon M Blanch, Heika R Tait, Herminio C Francisco, Hugh Grimoldby, Humberto Z Gomez, Ian J Thomson, James C Henry, James D Hildreth, James R Fleckenstein, James R Montero, James S Cartwright, James W Whitney, Jane M Kreis, Janet Pulver, Jeanne M Weishaar, Jeffrey J Leclair, Jenn W Sellers, Jessica L Kocian, Joan T Briones, Jocelyn E Massey, Jocelyn T Ramos, Joel D Martinez, John E Emmert, John S Hartford, John W Banks, Jonathan T Little, Joseph A Seitz, Julian C Hanson, Kara A Scheibner, PhD, Kathryn A Krentz, Katlin N Stubbs, Kenneth A Miles, Kent A Conforti, Kevin A Gonzalez, Kevin P Foley, Kimberly Lewandowski Walker, Kirstida Patel, Kirtida Patel, Kurt M Hafer, Lauren E Swantko, Leonard H Lavi, Linda S Leja, Linh Tu, Lisa K Capron, Lori J Silverstein, Lorna F Jones, M Patriciaurphy Murphy, Mai Hang, Maira P Brading, Marc R Dickens, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mark C Saale, Mark E Imsland, Mark W Babbitt, Marlo Ianm Alintanahin, Mary Ewilkerson Brinsko, Mary R Hole, Maya M Davis, Melkamu Getie Kebtie, PhD, Mendoza O Wallace, Michael D Garcia, Michael J Lackey, Michelle J Hines, Michelle M Noe, Michelle Rfrazier Jessen, PhD, Mohsen Rajabi Abhari, FDA, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy E Doyle, Nathan R Moon, Neali H Lucas, Nealie C Newberger, Neil J Traaen, Neira Acevedo Ramos, Paul F Rader, Paul L Yeh, Paul M Kawamoto, Paul R Whitby, Peter T Regan, Phal K Chhun, Philip E Ake, Philippe A Cornet, Phillip M Pontikos, Raffi B Papazian, Rebecca T Davis, Richmond K Yip, Robert D Tollefsen, Robert S Sweeton, Roger F Zabinski, Ronald E Gill, Ruben C Ayala, PharmD, S Lori Brown, PhD MPH, Sandra S Saniga, Savini, Scott A Nabe, Shannon J Hall, Shaquenta Y Perkins, Sharon I Gundersen, Shelley H Beausoleil, Sheri N Rohlf, Sherri N Rohif, Simone E Pitts, Stanley B Eugene, BS, BME, State Agency, Stephen R Souza, Sunitha K Rajaram, PhD, Sunny R Muir, Susanne M Richardson, MSc RAC ELS, Suyang Qin, Tawny L Colling, Teena H Aiken, Thao T Kwan, Thea C Grome, Thomas R Beilke, Timothy C Grome, Timothy P Lafave, Tracy K Li, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica Bush, Veronica L Bush, Victor A Meo, Victoria M Daddeo, Vining, Wayne T Smith, William J Foust, Xiaojun Yan, Yumi J Hiramine, Yvette E Guillermo, Zachary P Wachlarowicz

Sherri N Rohlf, MD's Documents

Publish Date	Document Type	Title
December, 2013	FDA 483	Pharma Tech Solutions, Inc - Form 483, 2013-12-09
September, 2014	FDA 483	FibroGen Incorporated - Form 483, 2014-09-19
January, 2018	FDA 483	Sam Van Boxstael, M.D. - Form 483, 2018-01-19
July, 2020	FDA 483	Philip M. Bolton, M.D. - Form 483, 2020-07-23
August, 2014	FDA 483	Rodo Medical, Inc. - Form 483, 2014-08-01
August, 2012	FDA 483 Response	Michael E. Ring, MD - Form 483R, 2012-09-14
September, 2014	EIR	FibroGen Incorporated - EIR, 2014-09-19
August, 2021	FDA 483	Augusto E. Focil, M.D. - Form 483, 2021-08-27
August, 2015	FDA 483	Andrew Blauvelt, MD, MBA - Form 483, 2015-08-10
June, 2014	FDA 483	Solta Medical, Inc. - Form 483, 2014-06-17
March, 2020	FDA 483	Kyowa Kirin Pharmaceutical Research, Inc. - Form 483, 2020-03-06
December, 2014	FDA 483	Makoto Tahara, MD, PhD - Form 483, 2014-12-05
November, 2018	FDA 483	May Y. Huang, M.D. - Form 483, 2018-11-29
April, 2021	FDA 483 Response	Brock A. McConnehey, DO - Form 483R, 2021-04-07
June, 2011	FDA 483	Inovise Medical, Inc. - Form 483, 2011-06-01
September, 2013	EIR	James W. Baker, MD - EIR, 2013-09-19
August, 2014	FDA 483 Response	Rodo Medical, Inc. - Form 483R, 2014-08-21
June, 2022	FDA 483	Christine H. Lee, M.D. - Form 483, 2022-06-17
February, 2019	FDA 483	Mitali Wadekar, M.D. - Form 483, 2019-02-01
May, 2016	FDA 483 Response	James W. Baker, MD - Form 483R, 2016-06-16
August, 2023	FDA 483	Mark A. Stein, Ph.D. - Form 483, 2023-08-04
April, 2013	EIR	Arifulla Khan MD - EIR, 2013-04-10
September, 2013	FDA 483 Response	James W. Baker, MD - Form 483R, 2013-10-08
August, 2010	FDA 483	Philips North America LLC - Form 483, 2010-08-09
April, 2013	FDA 483	Arifulla Khan MD - Form 483, 2013-04-10
June, 2017	FDA 483 Response	James W. Baker, MD - Form 483R, 2017-07-10
August, 2021	FDA 483	David L. Wirta, M.D. - Form 483, 2021-08-13
August, 2010	EIR	Philips North America LLC - EIR, 2012-08-29
August, 2021	EIR	Augusto E. Focil, M.D. - EIR, 2021-08-27
August, 2019	FDA 483	Tooraj J. Raoof, M.D. - Form 483, 2019-08-02
December, 2020	EIR	Andrew Blauvelt, MD, MBA - EIR, 2020-12-08
January, 2018	FDA 483	Krzysztof Wilk, M.D., Ph.D. - Form 483, 2018-01-26
September, 2013	FDA 483	James W. Baker, MD - Form 483, 2013-09-19
February, 2017	FDA 483	Patricia L. Norris, MD - Form 483, 2017-02-10
May, 2021	FDA 483	Chafic Karam, M.D. - Form 483, 2021-05-03
May, 2016	EIR	James W. Baker, MD - EIR, 2016-05-26
October, 2015	FDA 483	Cheta Nand, M.D. - Form 483, 2015-11-19
April, 2012	FDA 483	Commed, Inc. - Form 483, 2012-04-02
April, 2016	FDA 483	Bruno Carneiro De Medeiros, M.D. - Form 483, 2016-04-29
October, 2022	FDA 483	Maria W. Greenwald, MD - Form 483, 2022-10-27
April, 2021	FDA 483	Brock A. McConnehey, DO - Form 483, 2021-04-02
April, 2022	FDA 483	Sant P. Chawla, MD - Form 483, 2022-04-15
June, 2017	FDA 483	James W. Baker, MD - Form 483, 2017-09-20
April, 2018	FDA 483	Calcagno, Frank A. MD - Form 483, 2018-04-30
August, 2012	FDA 483	Michael E. Ring, MD - Form 483, 2012-09-13
November, 2014	FDA 483	Alexander E. Horwitz, III, M.D. - Form 483, 2014-11-14
December, 2014	FDA 483	Eun Kyung Lee, MD, PhD - Form 483, 2014-12-12
December, 2012	FDA 483	Ocular Concepts LLC - Form 483, 2012-12-05
February, 2017	EIR	Patricia L. Norris, MD - EIR, 2017-02-10
February, 2012	FDA 483	Global Pathogen Solutions, Inc - Form 483, 2012-02-28
January, 2013	FDA 483	Genesis Northwest, Incorporated - Form 483, 2013-02-22
October, 2017	FDA 483	UNIVERSITY OF OREGON - Form 483, 2017-10-17
December, 2012	FDA 483	Maloney's Custom Ocular Prosthetics - Form 483, 2012-12-05
June, 2021	EIR	Stephen G. Thein, Ph.D. - EIR, 2021-06-18
May, 2022	FDA 483	Brock A. Andersen, M.D. - Form 483, 2022-05-20
August, 2012	EIR	Michael E. Ring, MD - EIR, 2012-08-23
December, 2022	FDA 483	Joshua M. Smith, M.D., MBA - Form 483, 2022-12-08
October, 2019	FDA 483	Roger A. Dailey, M.D. - Form 483, 2019-10-02
March, 2019	FDA 483	Mohammad A. Mahmud, M.D. - Form 483, 2019-03-01
July, 2021	FDA 483	Sujith R. Kalmadi, MD - Form 483, 2021-07-16
April, 2021	EIR	Brock A. McConnehey, DO - EIR, 2021-04-02
February, 2017	FDA 483 Response	Patricia L. Norris, MD - Form 483R, 2017-03-01
November, 2013	FDA 483	Orchid Orthopedic Solutions Oregon, Inc. - Form 483, 2013-11-13
August, 2018	FDA 483	WCG IRB, Inc - Form 483, 2018-08-24
June, 2017	EIR	James W. Baker, MD - EIR, 2017-06-19
March, 2022	FDA 483	David R. Greeley, MD - Form 483, 2022-03-25
October, 2015	FDA 483 Response	Cheta Nand, M.D. - Form 483R, 2015-11-25
October, 2015	EIR	Cheta Nand, M.D. - EIR, 2015-10-30
August, 2015	EIR	Andrew Blauvelt, MD, MBA - EIR, 2015-08-10
May, 2016	FDA 483	James W. Baker, MD - Form 483, 2016-05-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more